TI
DMAC icon

Trexquant Investment’s DiaMedica Therapeutics DMAC Stock Holding History

Trexquant Investment’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$596K Buy
84,648
+62,387
+280% +$383K ﹤0.01% 1596
2026
Q1 		$151K Sell
22,261
-8,693
-28% -$68.9K ﹤0.01% 1683
2025
Q4 		$246K Buy
+30,954
New +$231K ﹤0.01% 1488
2021
Q3 		– Sell
-17,019
Closed -$76K – 1213
2021
Q2 		$76K Buy
+17,019
New +$140K 0.01% 1033

Other funds holding DMAC

CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Trexquant Investment's DMAC Position: Q2 2026 in Review

Trexquant Investment increased its DiaMedica Therapeutics (DMAC) stake by 280% in Q2 2026, buying an estimated $383K and bringing the position to 84,648 shares worth $596K. The position accounts for ﹤0.01% of the portfolio, ranked #1596.

Trexquant Investment first reported a position in DMAC in Q2 2021 and has held it in 4 quarters since. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • Trexquant Investment held 84,648 shares of DiaMedica Therapeutics worth $596K as of Q2 2026.
  • Trexquant Investment bought 62,387 DiaMedica Therapeutics shares in Q2 2026, an estimated $383K.
  • DiaMedica Therapeutics made up ﹤0.01% of Trexquant Investment's portfolio in Q2 2026, its #1596 holding.
  • Trexquant Investment first reported a position in DiaMedica Therapeutics in Q2 2021 and has held it in 4 quarters since.
  • 89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.